1
3D BIOTEK PRESENTS 3D CELL CULTURE WORKSHOP
November 17, 2010
3D BIOTEK PRESENTS 3D CELL CULTURE WORKSHOP November 17, 2010 1 - - PowerPoint PPT Presentation
3D BIOTEK PRESENTS 3D CELL CULTURE WORKSHOP November 17, 2010 1 Overview Introduction to 3D Biotek and its Products - Irina Briller, MBA, Marketing Associate 3D Cell Seeding Protocol, Routine Cell Culture and Stem Cell Research in 3D -
1
November 17, 2010
2
3
Business Stem Cells, Tissue Engineering, Medical Devices, Engineered Disease Model Core Technology Precision 3D Micro-Fabrication, Advanced Bio- Manufacturing Coating Process; Porous Tubular Implant Fabrication Patents: USA (4), China (2), International (2) Accomplishments Two product lines launched in 2008; 3D Cell Transfection Kit launched 4/2010; Bone defect repair and peripheral vascular stent product under development
5
6
1665, Hooke discovered “cells” 1838, Schleiden & Schwann “cell theory” 1885, Wilhelm Roux Cells can live outside the body 1907, Harrison Inventor of tissue culture 1952, Gey HeLa cells 1955, Eagle defined medium 1965, Ham Colonial growth
cells 1981, Martin & Evans Mouse ES cells 1998, Thomson & Gearheart Human ES cells
Ready to use 100% interconnected pores High surface to volume ratio Variable configurations (customizable) Easy cell recovery Plate reader compatible Transparency (direct
light microscope) The Ideal Scaffold Gel Matrices PLA foam CaP foam Alginate Foam 3D Collagen Scaffold 3D OPLA Scaffold 3D Calcium Phosphate Scaffold AlgiMatrix Matrigel / PuraMatrix / Coatings
Compatible Not Compatible
8
9 9
3D InsertTM-PCL 3D InsertTM-PS
10
11
2D 3D InsertTM-PS 3D InsertTM-PCL 6 well 6 well 6 well 9.6 cm2 1520 54.02 cm2 3030 99.21 cm2 3040 52.10 cm2 3050 75.62 cm2 12 well 12 well 12 well 4 cm2 1520 21.08 cm2 3030 39.27 cm2 3040 19.65 cm2 3050 27.90 cm2 24 well 24 well 24 well 1.9 cm2 1520 10.20 cm2 3030 18.28 cm2 3040 9.56 cm2 3050 13.74 cm2 48 well 48 well 48 well 1 cm2 1520 4.28 cm2 3030 7.74 cm2 3040 3.78 cm2 3050 6.08 cm2 96 well 96 well 96 well 0.32 cm2 1520 1.36 cm2 3030 2.03 cm2 3040 1.21 cm2 3050 1.53 cm2
13 13
14
Example: 96-well compatible PS scaffolds
15
3 h incubation 37º C, 5% CO 2
16
17
18 18
19
NIH-3T3 cells cultured in 96-well 2D TCPs and on 96- well compatible PS scaffolds. Dapi: blue, F-actin: green, Fibronectin: red.
2D TCP 3D PS
pore pore
Fluorescence Confocal
20
Proliferating human mesenchymal stem cells (hMSCs) were cultured on PS scaffolds (150 µm pore size, 200 µm fiber diameter). At day 5, viable cells and their secreted extra- cellular matrix were stained for nuclei (DAPI, blue) and Fibronectin (primary mouse antibody and secondary rabbit-anti-mouse AlexaFluor 594, red). Human mesenchymal stem cells (hMSCs) were seeded
diameter) and cultured under osteogenic conditions. At day 7, fluorescent imaging shows that osteoblastic cells are viable (A-C) and extend into pores of the PCL scaffold (B) (F-actin: green, DAPI: blue, A: 40X, B-C: 200X).
21 21
22
Hematopoietic Stem Cells (blood) Mesenchymal Stem Cells
Osteoblasts Osteoblastogenesis
Adipocytes Adipogenesis
Chondrocytes Chondrogenesis
Differentiation Process Lineage Cell Type
differentiation-promoting factors into cell culture media
23
Human mesenchymal stem cells (hMSCs) on PS scaffolds cultured using
Kossa assay.
Day 14 Day 21
Stereo Microscope 2D 3D 2D 3D
A B C D E F
2D 3D 2D 3D
24
2D 3D Lipid Droplets
0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5 Week 1 Week 2 Week 3 Week 4 2D 3D
OD560
Oil-Red-O Staining for Lipid Droplets
* * * *
p≤0.05
Human mesenchymal stem cells (hMSCs) on PS scaffolds cultured using adipocytic conditions and stained for lipid droplet formation using Oil-Red-O staining.
25
3D PS Scaffolds 2D TCP
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 1 2 3 4
Time (Weeks) Collagen mg/ml
Chondrogenesis (3D) Chondrogenesis (2D) Control (3D) Control (2D)
Week 1 Week 2 Week 3 Week 4
Human mesenchymal stem cells (hMSCs) on PS scaffolds cultured using chondrocytic conditions and stained for collagen formation.
26
26
27 3D Transfection. Using the 3D Cell Transfection Kit, 2x105 NIH-3T3 fibroblastic (A-C) and SH5Y neuronal (D) cells were simultaneously seeded and transfected with EGFP. 3D EGFP expression was monitored by fluorescence microscopy 24 h (NIH- 3T3 cells, A-C) and 48 h (SH5Y cells, D) post-
A B C D
Greater and extended IL-2 cytokine secretion in 3D. HEK293T were seeded and transfected in 2D (10x103 cells, 0.25 µg IL-2 cytokine plasmid, 0.5 µl commercial transfection reagent) and 3D (200x103 cells, 0.5 µg IL-2 cytokine plasmid, 3 µl 3D Transfection Reagent). IL-2 secretion was measured by ELISA assay at each time-point.
28
3D InsertTM-PS/Transfection Reagent: Cell Lines Used
HEK293 (Kidney Cells) NIH3T3 (Fibroblast) MCF-7 (Breast Cancer) MEF (Embryonic Fibroblast) SH5Y (Neuroblastoma) U87 (Glyoblastoma astrocytoma) VERO (Monkey kidney cells) 1˚ Rat Fibroblast 1˚ H. Neuroblastoma
29 29
30
Debnath J, et al. 2003 Fishbach C, et al. 2007
31
32
MCF-7 cells imaged using a light microscope in real-
0.1 0.2 0.3 0.4 0.5 0.6 0.7 Day 1 Day 4 Day 7 Day 14 2D 3D 0.05 0.1 0.15 0.2 0.25 Day 1 Day 4 Day 7 2D 3D
Absorbance (570 nm) Sustained cell viability in cells cultured on 3D PS scaffolds. MCF-7 human breast cancer cells were cultured in 2D and on 3D PS scaffolds. Cell viability was measured by (A) MTT and (B) Alamar blue assay.
MTT assay
Absorbance (570/405 nm)
Alamar Blue * * * * * * *
p≤0.05
33
0.2 0.4 0.6 0.8 1 4 7 10 13 4 7 10 13 4 7 10 13
5000 10000 15000 20000 25000 DNA (ng per well) 2D 3D
control + E2 + E2 + FUL
Enhanced MCF proliferation in 3D after estrogen stimulation. DNA assay was performed to determine proliferation response.
DNA assay * ^
&
p≤0.05
Absorbance (570 nm) con 10-6 M 10-5 M
Day
Effects of tamoxifen on MCF-7 cells grown in 2D and 3D. Cell viability after tamoxifen treatment was measured by MTT assay.
MTT assay
2D 3D
* * * * * * * * * *
34
A B
HepG2 cells imaged using a light microscope in real-
10000 20000 30000 40000 50000 60000 70000
2D 3D
Rifampicin
CYP3A Activity RLU
50000 100000 150000 200000 250000 300000
2D 3D
Rifampicin
RLU Viability HepG2 cells cultured on 2D TCP and in 96-well compatible PS scaffolds were treated with Rifampicin and assayed for CYP3A induction and cell viability.
*
p≤0.05
35 35
Non-Hodgkin Lymphoma Proliferation
+ Stroma
3D 2D Day 0 1,000 1,000 Day 7 197,222 +/- 23,940 55,777 +/- 8.071 % Surplus 19,722 5,577
36 36
Doris Taylor, University
Minnesota: Stem Cell Institute, 2008 “Ear Mouse”
38
Human dermal fibroblasts cultured
96-well compatible PS scaffolds. DAPI: blue, F-actin: green, (A: 100x, B: 200X).
0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18
Day 3 Day 6 2D 3D
Neutral Red Assay
Absorbance (560 nm)
Human epidermal keratinocytes (neonatal) cultured in 96-well 2D TCPs and on 96-well compatible PS scaffolds. PS fiber PS fiber
p≤0.05
39
Human mesenchymal (hMSC) and fibroblastic (hFB) cultured on PCL scaffolds. For the duration
media and hMSCs were cultured using osteoblastic
assayed for alkaline phosphatase activity (A), calcium deposition (B), and stained for mineralization with Von Kossa (C).
A B C
5 1 1 5 20 25 30 35 40 45
Week 4 hFB hMSC
Calcium Deposition Absorbance (OD490 nm)
5 1 1 5 20 25 30 35 40 45
Week 4 hFB hMSC
Calcium Deposition Absorbance (OD490 nm)
*
0.001 0.002 0.003 0.004 0.005 0.006 0.007 0.008 0.009 0.01
Week 1 Week 2 Week 3 Week 4 hFB hMSC Alkaline Phosphatase Activity uM/minute/ng DNA/well
0.001 0.002 0.003 0.004 0.005 0.006 0.007 0.008 0.009 0.01
Week 1 Week 2 Week 3 Week 4 hFB hMSC Alkaline Phosphatase Activity uM/minute/ng DNA/well
* * * *
p≤0.05
40 40
3D InsertTM-PCL
Collagen Poly-D-Lysine Fibronectin
41 41
42 42
Huihui Mou, Yannan He, Kanghong Hu, State Key Laboratory of Virology, Institute
PR China
44
Compatible Assays
Cell lifting and tissue digestion
(Trypsin/Trypsin-EDTA, Collagenase)
RNA isolation
(Tri-Reagent)
Protein Assays
(Western Blot, ELISA)
Proliferation Assays
(DNA Assay [fluorescent detection], Alamar Blue, MTT, Neutral Red)
Cell Transfections
(Transient [baculovirus], and Stable)
Differentiation Assays
(ALP Activity, In Situ Collagen Content, GAG Characterization)
Characterization Stains
(Von Kossa, Oil-Red-O, Alcian Blue, Sirius Red, Albumin)
Immunofluorescence and Immunohistochemistry
*readily compatible with inverted light and fluorescent microscopes
Viability and Toxicity Assays
(Multiplexing Assays, ADME/Tox Assays) *readily compatible with microplate readers
45
Cell Lines Cultured on 3D InsertTM-PS/PCL
Tumor cells MCF-7 MCF-7:WS8 ECC1 HepG2 LYRH Stem Cells Human Mesenchymal Stem Cells (hMSCs) Mouse bone marrow stromal stem cells (mBMSSCs) Hepatocytes Huh-7 HepG2 Osteoblasts 7F2 hMSC-derived osteoblasts Chondrocytes hMSC-derived chondrocytes Adipocytes hMSC-derived adipocytes Neural cells SH5Y U87 Cardiomyocytes H9c2 Rat primary cardiomyocytes Keratinocytes Human keratinocytes, neonatal (HEKn) Epithelial cells MCF-10A HEK293T Fibroblasts Human fibroblasts, adult NIH-3T3 L929
3D InsertTM-PS 3D InsertTM-PCL
46
47 47
Collaborations
48
Awards: 2010
entitled “Engineered Polystyrene Scaffolds For In Vitro Three-Dimensional Disease Models,” was nominated as an outstanding contribution to the Society For Biomaterials 2010 Annual Meeting
Awards: 2009
Awards: 2008
49
Isn’t it time YOU see the world in 3D?
50 50
Irina Briller, MBA Carlos Caicedo, Ph.D.
Marketing and Sales Research Scientist 732-729-6270, ext. 4105 732-729-6270, ext. 4106 ibriller@3dbiotek.com ccaicedo@3dbiotek.com Chris Gaughan, Ph.D. Nobel Vale, M.S. Research Scientist Research Scientist 732-729-6270 732-729-6270 ext. 4108 cgaughan@3dbiotek.com nvale@3dbiotek.com
51 51